Clinical importance of potential genetic determinants affecting propofol pharmacokinetics and pharmacodynamics

I Budic, T Jevtovic Stoimenov, D Pavlovic… - Frontiers in …, 2022 - frontiersin.org
Interindividual variability in response to drugs used in anesthesia has long been considered
the rule, not the exception. It is important to mention that in anesthesiology, the variability in …

Model‐informed drug development: The mechanistic HSK3486 physiologically based pharmacokinetic model informing dose decisions in clinical trials of specific …

M Zhang, Z Yu, H Liu, X Wang, H Li… - … & Drug Disposition, 2023 - Wiley Online Library
HSK3486, a central nervous system inhibitor, has demonstrated superior anesthetic
properties in comparison with propofol. Owing to the high liver extraction ratio of HSK3486 …

Influence of clinical and genetic factors on propofol dose requirements: A genome-wide association study

S Ahlström, P Reiterä, R Jokela, KT Olkkola… - …, 2024 - pubs.asahq.org
Background Propofol is a widely used intravenous hypnotic. Dosing is based mostly on
weight, with great interindividual variation in consumption. Suggested factors affecting …

Personalized medicine for classical anesthesia drugs and cancer progression

B Costa, J Mourão, N Vale - Journal of Personalized Medicine, 2022 - mdpi.com
In this review, we aim to discuss the use and effect of five different drugs used in the
induction of anesthesia in cancer patients. Propofol, fentanyl, rocuronium, sugammadex …

GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility

Y Zeng, S Cao, M Chen, C Fang… - Pharmacogenomics and …, 2022 - Taylor & Francis
Purpose To explore the effect of gene polymorphisms of propofol GABAA receptor and
metabolic enzyme on drug susceptibility during the induction period of general anesthesia …

[HTML][HTML] Mechanisms and implications in gene polymorphism mediated diverse reponses to sedatives, analgesics and muscle relaxants

Y Sun, H Zhu, E Esmaeili, X Tang… - Korean Journal of …, 2023 - synapse.koreamed.org
Responses to sedatives, analgesics and muscle relaxants vary among patients under
general anesthesia, which could be ascribed to the disparities of clinical characteristics and …

Polymorphisms of pharmacogenetic candidate genes affect etomidate anesthesia susceptibility

L Ma, Y Huang, S Huang, F Xu, Y Wang, S Zhao… - Frontiers in …, 2022 - frontiersin.org
Purpose: Etomidate is widely used in general anesthesia and sedation, and significant
individual differences are observed during anesthesia induction. This study aimed to explore …

The Influence of CYP2B6 Variants and Administration of Propofol on Patient Outcomes after Traumatic Brain Injury

K O'Meara, AM Puccio, D Ren, S Deslouches… - Neurotrauma …, 2024 - liebertpub.com
Management of severe traumatic brain injury (sTBI) typically involves the use of sedation,
which inherently results in benefits and risks. The cytochrome P450 enzyme CYP2B6 is …

Pharmacogenetic Gene–Drug Associations in Pediatric Burn and Surgery Patients

KN Grimsrud, RR Davis, CG Tepper… - Journal of Burn Care & …, 2022 - academic.oup.com
Management of critically ill patients requires simultaneous administration of many
medications. Treatment for patient comorbidities may lead to drug–drug interactions which …

Altitude effect on Propofol Pharmacokinetics in Rats

L Li, X Wang, S Wang, L Wen… - Current Drug …, 2024 - ingentaconnect.com
Background: Propofol is an intravenous agent for clinical anesthesia. As the influence of the
hypobaric-hypoxic environment (Qinghai-Tibetan region, altitude: 2800-4300 m, PaO2: 15.1 …